| Home | Search | Study Topics | Glossary |
|
|
|
 |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Creutzfeldt-Jakob Disease | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Creutzfeldt-Jakob Syndrome | |||||
| 3 | More general conditions related to this trial | ||||
| Brain Diseases | |||||
| Central Nervous System Diseases | |||||
| Central Nervous System Infections | |||||
| Delirium, Dementia, Amnestic, Cognitive Disorders | |||||
| Dementia | |||||
| Mental Disorders | |||||
| Nervous System Diseases | |||||
| Prion Diseases | |||||
| 4 | Interventions listed in this trial | ||||
| Quinacrine | |||||
| 5 | More general drug interventions related to this trial | ||||
| Anthelmintics | |||||
| Anti-Infective Agents | |||||
| Anticestodal Agents | |||||
| Antimalarials | |||||
| Antinematodal Agents | |||||
| Antineoplastic Agents | |||||
| Antiparasitic Agents | |||||
| Antiplatyhelmintic Agents | |||||
| Antiprotozoal Agents | |||||
| Enzyme Inhibitors | |||||
| Molecular Mechanisms of Pharmacological Action | |||||
| Pharmacologic Actions | |||||
| Therapeutic Uses | |||||
| 6 | Sponsors listed in this trial | ||||
| National Institute on Aging (NIA) | |||||
|
